The applications of anti-CD20 antibodies to treat various B cells disorders - ScienceDirect
anti-CD20 (Rituximab) - ACE Biolabs Antibody │ Chemical │ Enzyme
Anti-CD20 monoclonal antibodies: historical and future perspectives | Haematologica
AntiCD20+ Agents - Practical Neurology
Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis - Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
The future of anti-CD 20 monoclonal antibodies : are we making progress ? | Semantic Scholar
SciELO - Brasil - CD20 role in pathophysiology of Hodgkin's disease CD20 role in pathophysiology of Hodgkin's disease
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises | Immunotherapy
Lymphoma: Radioimmunotherapy Using Iodine-131 Labeled Murine Anti-CD20 Antibodies (131I-Tositumomab and Tositumomab, “Bexxar”) | Radiology Key
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance | Oncogene
Frontiers | Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells
HEK293 Expressed Full Length CD20 Protein with Nanodisc / DDM - ACROBiosystems
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives | SpringerLink
CD20 Monoclonal Antibodies Drugs: There is an Explosion of New mAbs Against CD20! - Cusabio
Mechanisms of action of anti-CD20 monoclonal antibodies. Abbreviation:... | Download Scientific Diagram
Anti-tumor antibody (anti-CD20)-opsonized tumor cells (A) and... | Download Scientific Diagram
The effects of type I and type II anti-CD20 mAb binding to CD20 on... | Download Scientific Diagram
Treatment of multiple sclerosis with anti-CD20 antibodies. | Semantic Scholar
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Frontiers | Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease | PNAS
CD20 - Wikipedia
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy
